Agile monitoring dashboard for clinical research studies

The Delirium and Neuropsychological Recovery among Emergency General Surgery Survivors (DANE) study (NCT05373017, 1R01AG076489-01) is a multi-site, two-arm, single-blinded randomized controlled clinical trial to evaluate the efficacy of the Emergency General Surgery (EGS) Delirium Recovery Model to improve the cognitive, physical, and psychological recovery of EGS delirium survivors over 65. The DANE study received approval from the University of Wisconsin-Madison/University of Wisconsin Hospitals and Clinics Institutional Review Board (IRB, no. 2022-0545, approval date September 14, 2022), and Indiana University agreed to cede IRB review to University of Wisconsin-Madison/University of Wisconsin Hospital and Clinics (September 29, 2022).

Authors

Institutions

Publication Details

Journal
Trials
Published
2024-11-29
DOI
https://doi.org/10.1186/s13063-024-08646-0
Citations
1
Primary Topic
Intensive Care Unit Cognitive Disorders
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Agile monitoring dashboard for clinical research studies

Sarah Robbins Scott, Cristina Barboi, Malaz Boustani, Ben L. Zarzaur et al.
1 citations
Trials
Intensive Care Unit Cognitive Disorders
0.42
article

Agile monitoring dashboard for clinical research studies

Sarah Robbins Scott, Cristina Barboi, Malaz Boustani, Ben L. Zarzaur, Emma Holler, Fatemehalsadat Shojaei, Peggy Bylund, Richard J. Holden, Fereshtehossadat Shojaei, Mark Seidman, Leah Leslie Gardner, Nicole R. Fowler
article en
1 citations

Abstract

The Delirium and Neuropsychological Recovery among Emergency General Surgery Survivors (DANE) study (NCT05373017, 1R01AG076489-01) is a multi-site, two-arm, single-blinded randomized controlled clinical trial to evaluate the efficacy of the Emergency General Surgery (EGS) Delirium Recovery Model to improve the cognitive, physical, and psychological recovery of EGS delirium survivors over 65. The DANE study received approval from the University of Wisconsin-Madison/University of Wisconsin Hospitals and Clinics Institutional Review Board (IRB, no. 2022-0545, approval date September 14, 2022), and Indiana University agreed to cede IRB review to University of Wisconsin-Madison/University of Wisconsin Hospital and Clinics (September 29, 2022).

TrialsVol. 25(1)
Indiana University Health (US), Regenstrief Institute (US), University of Wisconsin–Madison (US), Indiana University Bloomington (US), Eskenazi Health Foundation (US), Eskenazi Health, Indiana University – Purdue University Indianapolis (US)
Peace, Justice and strong institutions
Openalex Percentile: Top 33%
Intensive Care Unit Cognitive Disorders
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.